Head and Neck Cancers, Version 2.2013
David G. Pfister(Memorial Sloan Kettering Cancer Center), Miranda Hughes(National Comprehensive Cancer Network), Frank Dunphy, Frank Worden(University of Michigan), Sharon A. Spencer(University of Alabama at Birmingham), Nicole R. McMillian, Ellie Maghami(City Of Hope National Medical Center), Barbara Burtness(Yale University), Jatin P. Shah(Memorial Sloan Kettering Cancer Center), Ying J. Hitchcock(University of Utah), Anthony J. Cmelak(Breast Cancer Research Foundation), David M. Brizel(Duke University), Randal S. Weber(The University of Texas MD Anderson Cancer Center), Paul M. Busse(Massachusetts General Hospital), John A. Ridge(Fox Chase Cancer Center), Bruce H. Haughey(AdventHealth Celebration), Jimmy J. Caudell(Moffitt Cancer Center), A. Dimitrios Colevas(Cancer Institute (WIA)), Wesley L. Hicks, Maura L. Gillison(The University of Texas MD Anderson Cancer Center), Robert I. Haddad(Georgetown University), Sue S. Yom(University of California, San Francisco), Gregory T. Wolf(University of Michigan), William M. Lydiatt(Creighton University), David E. Schuller(Ohio State University Hospital), Renato Martins(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jill Gilbert(Cancer Clinic), Merrill S. Kies(The University of Texas MD Anderson Cancer Center), Sandeep Samant, Kie-Kian Ang(Radiation Oncology Associates), Thomas V. McCaffrey, Bharat B. Mittal(Northwestern University), Harlan A. Pinto(Cancer Institute (WIA)), David W. Eisele(Sidney Kimmel Comprehensive Cancer Center)
Cited by 164
Related Papers
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
|Journal of Clinical Oncology|2011|3.6k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k